Every material Form 8-K Iveda Solutions, Inc. has filed with the SEC since February 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Nasdaq granted Iveda Solutions an additional 180 calendar days, until March 1, 2027, to regain compliance with its $1.00 minimum bid price rule, after the company requested the extension on September 2, 2026. The extension delays a possible delisting, but the stock must still close at or above $1.00 for at least 10 consecutive business days, and the company has not decided on a reverse stock split.
Nasdaq first notified Iveda on March 6, 2026, that its closing bid price had been below $1.00 for 30 consecutive business days.
Iveda received the second grace period letter from Nasdaq on September 4, 2026, extending the deadline to March 1, 2027.
Iveda may consider a reverse stock split if appropriate, but has not announced a decision to implement one.
The company may still be delisted during the period if it fails other Nasdaq listing requirements, and Nasdaq would issue a delisting notice if compliance is not shown by March 1, 2027.
On March 6, 2026, Iveda Solutions received a Nasdaq letter stating its common stock failed to maintain a minimum bid price of $1 per share over the last 30 consecutive business days, a breach of Nasdaq Rule 5550(a)(2). The notice has no immediate effect on the listing, and the company has until September 2, 2026 to regain compliance, after which Nasdaq could begin delisting proceedings if it has not.
Nasdaq letter dated March 6, 2026 cites closing bid price below $1 for 30 consecutive business days
Compliance period of 180 calendar days runs until September 2, 2026
Regaining compliance requires a closing bid price of at least $1 for ten consecutive business days
If not compliant by the deadline, the company could face delisting, with the right to appeal to a Nasdaq Hearings Panel
Iveda Solutions closed a public offering on February 11, 2026, selling 5,259,999 common shares at $0.35 each, plus pre-funded warrants and Series X Warrants, for aggregate gross proceeds of approximately $2 million before fees and expenses. The warrants could add up to 11,428,572 more shares, which would dilute existing shareholders, and the company intends to use the proceeds for general corporate purposes.
Closed February 11, 2026: 5,259,999 shares at $0.35 per share, plus pre-funded warrants for up to 454,287 shares at $0.3499 each
Series X Warrants for up to 11,428,572 shares at $0.35 per share, expiring two years after issuance
Placement agent H.C. Wainwright received a 7.0% cash fee ($140,000), warrants for 400,000 shares, and $100,000 in legal expense reimbursement; the company agreed not to issue new shares for up to 12 months, subject to exceptions
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Iveda Solutions, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →